MedTrace Logo

Monitoring of Patients With Asthma Performed by a Clinical Pharmacist Using a Mobile Application

NCT05503342 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-08-16

No results posted yet for this study

Summary

Asthma is a chronic inflammatory disease that affects the lungs. In Brazil it is responsible for about 4 to 8 deaths per day. Pharmacotherapeutic follow-up programs for people with asthma have a positive impact on treatment adherence, as well as on education about the disease, helping patients in their self-management and recognition of their health status. The use of mobile applications that assist in the monitoring and self-management of people with asthma has been increasing significantly, but we do not have much information about their real impact on the control of the disease. Thus, the aim of this study is to evaluate the use of a mobile application in the monitoring and self-management of symptoms in adults with asthma in a pharmaceutical care program at a university outpatient clinic in São Paulo, Brazil.

Conditions

Interventions

OTHER

Mobile Application

Use of the cell phone application to include information about asthma symptoms which had returned with guidance on self-management.

OTHER

Asthma control assessment

Asthma control assessment questionnaire application in paper format

Sponsors & Collaborators

  • Federal University of Amazonas

    collaborator OTHER

  • Rafael Stelmach

    lead OTHER

Principal Investigators

  • Rafael Stelmach · University of Sao Paulo General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-29
Primary Completion
2022-04-23
Completion
2022-04-23

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05503342 on ClinicalTrials.gov